Medi-Physics Inc. dba GE Healthcare is recalling 110 vials of Thallous Chloride TI 201 Injection, a prescription radiopharmaceutical drug used in medical imaging. The recall was initiated because trace amounts of an impurity were detected in a reagent used during the manufacturing process, which could contaminate the finished product. Consumers should be aware that this specific lot was distributed nationwide across the United States.
The presence of trace impurities in an injectable medication may lead to unintended chemical exposure. While the risk level is currently categorized as low, contaminated reagents can compromise the purity and safety of the final drug product.
Healthcare provider consultation and pharmacy return.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.